Table 1:
Clinical and haematological characteristics of the patients at allergeneic stem cell transplantation.
| Total no. Patients | 52 |
| Age | |
| Median (range) | 52,5 (32–68) |
| Diagnosis | |
| Idiopathic myelofibrosis | 36/44 (82%) |
| Secondary myelofibrosis | 8/44(18%) |
| Time diagnosis-SCT (months) | |
| Median (range) | 13 (1–162) |
| ≤ 12 | 21/52 (40%) |
| 13–35 | 14/52 (27%) |
| ≥ 36 | 17/52 (33%) |
| Dupriez score at transplant | |
| Low | 5/44 (11%) |
| Intermediate | 30/44 (68%) |
| High | 9/44 (21%) |
| Previous transfusions | 18/40 (45%) |
| Karyotype | |
| Normal | 28/36 (78%) |
| Abnormal | 8/36 (22%) |
| Previous splenectomy | 20/46 (43%) |
| Splenomegaly at transplant | 22/43 (51%) |
| Circulating blasts at transplant | 11/41 (27%) |
| Hemoglobin level at transplant (g/dl) | |
| Median (range) | 9.1 (5.6–14.4) |
| White cell count at transplant (x 106/l) | |
| Median (range) | 7.7 (0.6–118) |